For Meniett therapy, you need a Ménière's disease diagnosis and prescription. You’ll also need a tiny vent tube placed in your eardrum. When you start Meniett therapy, be sure to follow your prescription and don’t skip any treatments. Meniett therapy can reduce your dizziness/vertigo so you can enjoy life again.1-12
Is It Right for You?
The Meniett device is most effective for dizziness and vertigo symptoms of Ménière's disease. Meniett therapy is a second-level treatment for Ménière's disease. It’s usually prescribed when diet and medication don’t help. More
Your Healthcare Team
Ear, nose, and throat (ENT) specialists and ear specialists (otologists, neurotologists) are the doctors who treat Ménière's disease. ENT specialists are also called otolaryngologists. More
Insurance Coverage and Financial Assistance
Meniett therapy is an FDA-cleared treatment for Ménière’s disease that is supported by significant research.1-12 But not all insurance companies cover it. Our Therapy Access department may be able to help you get coverage, and we also offer financial assistance. More
Get Your Meniett and Begin Therapy
Meniett therapy is a safe, simple, and effective treatment for Ménière’s disease symptoms.1-12 Once you and your doctor decide it’s right for your Ménière’s disease, these are the steps you’ll take. More
Your Meniett Treatment Plan
During the first 6 weeks, it's important to follow your prescription every day and don't skip any treatments. Most patients know within 6 weeks if their Ménière’s disease will respond to Meniett therapy. More
Questions and Answers
Here are answers to some common questions about Meniett therapy for Ménière’s disease. For medical questions about Ménière’s disease, ask your doctor. For Meniett questions, contact Meniett Customer Service at (877) 966-3350 or email us. More
Read about the experiences of people who have used Meniett therapy for their Ménière’s disease. You’ll learn what life was like for these Ménière’s disease patients, before and after Meniett therapy. More
Dornhoffer JL, King D. The effect of the Meniett device in patients with Ménière's disease: long-term results. Otol Neurotol 2008; 29(6):868-74.
Weining H, Fang L, Bo G, Jinmei Z. Clinical long-term effects of Meniett pulse generator for Ménière's disease. Acta Otolaryngol 2009; 129(8):819-825.
Mattox DE, Reichert M. Meniett device for Ménière's disease: use and compliance at 3 to 5 years. Otol Neurotol 2008; 29(1):29-32.
Barbara M, Monini S, Chiappini I, Filipo R. Meniett therapy may avoid vestibular neurectomy in disabling Ménière's disease. Acta Otolaryngol 2007; 127(11):1136-1141.
Nabi S, Parnes LS. Bilateral Ménière’s disease. Curr Opin Otolaryngol Head Neck Surg 2009; 17:356-362.
Thomsen J, Sass K, Ödkvist L, Arlinger S. Local over-pressure treatment reduces vestibular symptoms in patients with Ménière’s disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol 2005; 26:68-73.
Rajan GP, Din S, Atlas MD. Long-term effects of the Meniett device in Ménière’s disease: the Western Australian experience. J Laryngol Otol 2005; 119:391-395.
Densert B, Sass K. Control of symptoms in patients with Ménière’s disease using middle ear applications: A two-year follow-up. Acta Otolaryngol 2001; 121(5):616-621.
Gates GA, Green Jr. JD, Tucci DL, Telian SA. The effects of transtympanic micropressure treatment in people with unilateral Ménière’s disease. Arch of Oto – HNS 2004; 130(6):718-725.
Gates GA, Verrall A, Green Jr. JD, Tucci DL, Telian SA. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg 2006; 132:1311-1316.
Ödkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallquist J. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière’s disease: A clinical, multicenter, placebo-controlled study. Acta Otolaryngol Suppl 2000; 543: 99-101
Densert B, Densert O, Arlinger S, Sass K, Ödkvist LM. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Ménière’s disease: A clinical placebo-controlled study. Am J Otol 1997; 18:726-733.